OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Pharmacology is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Orofacial pain models induce impairment in spatial learning and working memory in rodents: A systematic review and meta-analysis	271
Molecular interplay between EIF4 family and circular RNAs in cancer: Mechanisms and therapeutics	172
Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82	139
Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy	115
Editorial Board	111
Amorphous selenium nanodots alleviate non-alcoholic fatty liver disease via activating VEGF receptor 1 to further inhibit phosphorylation of JNK/p38 MAPK pathways	102
Editorial Board	101
Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits perivascular sympathetic nerve stimulation-induced vasoconstriction in isolated renal artery	99
Editorial Board	92
Phosphodiesterase-1 inhibitor modulates Ca2+ regulation in sirtuin 1-deficient mouse cardiomyocytes	90
Editorial Board	88
RNAi in psoriasis: A melodic exploration of miRNA, shRNA, and amiRNA with a spotlight on siRNA	77
Melittin suppresses aerobic glycolysis by regulating HSF1/PDK3 to increase chemosensitivity of NSCLC	75
Corrigendum to “Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells” [Eur. J. Pharmacol. 938 (2023) 175411]	73
Validation and characterization of oxycodone physical dependence in C57BL/6J mice	72
Corrigendum to “Isopropyl 3-(3, 4-dihydroxyphenyl)-2-hydroxypropanoate protects lipopolysaccharide-induced acute lung injury in mice by attenuating pyroptosis” [Eur. J. Pharmacol. 5 (2023) 175545]	69
Comprehensive characterization of fatty acid oxidation in triple-negative breast cancer: Focus on biological roles and drug modulation	66
HSP90: A promising target for NSCLC treatments	65
Nanomedicine: A great boon for cardiac regenerative medicine	65
Autophagic inhibitor ROC-325 ameliorates glomerulosclerosis and podocyte injury via inhibiting autophagic flux in experimental FSGS mice	62
Effects of chronic mirabegron treatment on metabolic and cardiovascular parameters as well as on atherosclerotic lesions of WHHL rabbits with high-fructose high-fat diet-induced insulin resistance.	62
Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids	62
Sacubitril/valsartan in chronic kidney disease: From pharmacological mechanism to clinical application	60
Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia	57
Combining brief recall and ketamine treatment prevents stress-primed methamphetamine memory reinstatement via heightening mPFC GABA activity	56

Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension	56
The synergistic effects of opioid and neuropeptide B/W in rat acute inflammatory and neuropathic pain models	56
Inhibition of TRPC3 channels suppresses seizure susceptibility in the genetically-epilepsy prone rats	56
Suppression of hypoxia-induced CAV1 autophagic degradation enhances nanoalbumin-paclitaxel transcytosis and improves therapeutic activity in pancreatic cancer	55
Validating the temporal performance of genetic biomarkers in an animal model of recurrence/ non-recurrence myocardial infarction persuades by bioinformatics tools	54
Novel combinatorial autophagy inhibition therapy for triple negative breast cancers	54
3,3′-O-dimethylquercetin: A bi-functional vasodilator isolated from green propolis of the Caatinga Mimosa tenuiflora	53
Inhibiting PRMT1 protects against CoNV by regulating macrophages through the FGF2/PI3K/Akt pathway	52
IL-1 receptor-associated kinase family proteins: An overview of their role in liver disease	52
Molecular mechanism and therapeutic significance of dihydromyricetin in nonalcoholic fatty liver disease	51
Cyclin-dependent kinase 5 inhibitor attenuates lipopolysaccharide-induced neuroinflammation through metabolic reprogramming	51
Current progress on the mechanisms of hyperhomocysteinemia-induced vascular injury and use of natural polyphenol compounds	50
Efficacy of the neurotensin receptor 1 analog PD149163 in modulation of the kidney inflammation: Inhibition of the nuclear factor kappa β signaling pathway and oxidative stress in endotoxemic mice	50
TNF-alpha mediates airway hyperreactivity in silicotic mice: Effect of thalidomide treatment	49
Characterisation of bis(4-aminoquinoline)s as α1A adrenoceptor allosteric modulators	49
Suppression of hippocampal GABAergic transmission impairs memory in rodent models of Alzheimer's disease	48
Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation	47
Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing	47
Advancing health care via artificial intelligence: From concept to clinic	47
Isorhynchophylline ameliorates the progression of osteoarthritis by inhibiting the NF-κB pathway	46
Low-intensity pulsed ultrasound prevents angiotensin II-induced aortic smooth muscle cell phenotypic switch via hampering miR-17-5p and enhancing PPAR-γ	46
Phloretin and Enalapril co-administration ameliorates hyperglycemia mediated exacerbation of myocardial injury in rats	46